Abstract

Severe psychological trauma triggers genetic, biochemical and morphological changes in amygdala neurons, which underpin the development of stress-induced behavioural abnormalities, such as high levels of anxiety. miRNAs are small, non-coding RNA fragments that orchestrate complex neuronal responses by simultaneous transcriptional/translational repression of multiple target genes. Here we show that miR-483-5p in the amygdala of male mice counterbalances the structural, functional and behavioural consequences of stress to promote a reduction in anxiety-like behaviour. Upon stress, miR-483-5p is upregulated in the synaptic compartment of amygdala neurons and directly represses three stress-associated genes: Pgap2, Gpx3 and Macf1. Upregulation of miR-483-5p leads to selective contraction of distal parts of the dendritic arbour and conversion of immature filopodia into mature, mushroom-like dendritic spines. Consistent with its role in reducing the stress response, upregulation of miR-483-5p in the basolateral amygdala produces a reduction in anxiety-like behaviour. Stress-induced neuromorphological and behavioural effects of miR-483-5p can be recapitulated by shRNA mediated suppression of Pgap2 and prevented by simultaneous overexpression of miR-483-5p-resistant Pgap2. Our results demonstrate that miR-483-5p is sufficient to confer a reduction in anxiety-like behaviour and point to miR-483-5p-mediated repression of Pgap2 as a critical cellular event offsetting the functional and behavioural consequences of psychological stress.

The role of miRNAs in regulating brain stress response remains relatively unexplored. Here the authors show that miR-483-5p-mediated repression of Pgap2 in amygdala of male mice offsets the functional and behavioural consequences of stress.

Details

Title
miR-483-5p offsets functional and behavioural effects of stress in male mice through synapse-targeted repression of Pgap2 in the basolateral amygdala
Author
Mucha, Mariusz 1   VIAFID ORCID Logo  ; Skrzypiec, Anna E. 1 ; Kolenchery, Jaison B. 1 ; Brambilla, Valentina 1 ; Patel, Satyam 2 ; Labrador-Ramos, Alberto 1 ; Kudla, Lucja 3 ; Murrall, Kathryn 1 ; Skene, Nathan 4   VIAFID ORCID Logo  ; Dymicka-Piekarska, Violetta 5 ; Klejman, Agata 6 ; Przewlocki, Ryszard 3 ; Mosienko, Valentina 7   VIAFID ORCID Logo  ; Pawlak, Robert 1 

 University of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024) 
 Alberta Health Services, Pharmacy Department, Calgary, Canada (GRID:grid.413574.0) (ISNI:0000 0001 0693 8815) 
 Polish Academy of Sciences, Department of Molecular Neuropharmacology, Institute of Pharmacology, Krakow, Poland (GRID:grid.413454.3) (ISNI:0000 0001 1958 0162) 
 UK Dementia Research Institute at Imperial College London, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Imperial College London, Department of Brain Sciences, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 Medical University of Bialystok, Department of Clinical Laboratory Diagnostics, Bialystok, Poland (GRID:grid.48324.39) (ISNI:0000000122482838) 
 Polish Academy of Sciences, Nencki Institute of Experimental Biology, Warszawa, Poland (GRID:grid.413454.3) (ISNI:0000 0001 1958 0162) 
 University of Exeter Medical School, Department of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024); University of Bristol, School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603) 
Pages
2134
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2805752458
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.